- Roche stakes $700M on Nurix’s protein-degrading drug<p>Potentially worth up to $2.3 billion, the collaboration is a bet that drugs able to eliminate the “BTK” enzyme will prove superior to existing medicines that block its activity.</p>BioPharma Dive · 1mo ago↗ source
- Tango data add to growing momentum for pancreatic cancer drugs<figure><div><img src="https://imgproxy.divecdn.com/WEayUdfuHXoOw2FpmsOFLF4yn7KYNOFOwzm5w7xXaT4/g:ce/rs:fill:1600:900:1/Z3M6Ly9kaXZlc2l0ZS1zdG9yYWdlL2RpdmVpbWFnZS9HZXR0eUltYWdlcy0xMzE4Mjc5OTExLmpwZ…BioPharma Dive · 1mo ago↗ source
- Incyte to buy blood disorder drug in possibly $2B deal<figure><div><img src="https://imgproxy.divecdn.com/2QfDLQx7Ry-HALZnt9wJeCfUZIiqFEeEOc-a7yHR_O8/g:ce/rs:fill:1600:900:1/Z3M6Ly9kaXZlc2l0ZS1zdG9yYWdlL2RpdmVpbWFnZS9HZXR0eUltYWdlcy0xMzY2OTU4MDU4LmpwZ…